Literature DB >> 9168268

Neurobehavioral alterations in autoimmune mice.

B Sakić1, H Szechtman, J A Denburg.   

Abstract

Inbred MRL, NZB and BXSB strains of mice spontaneously develop a systemic, lupus-like autoimmune disease. The progress of autoimmunity is accompanied with a cascade of behavioral changes, most consistently observed in tasks reflective of emotional reactivity and the two-way avoidance learning task. Given the possibility that behavioral alterations may reflect a detrimental consequence of autoimmune-inflammatory processes and/or an adaptive response to chronic malaise, they are tentatively labeled as autoimmunity-associated behavioral syndrome (AABS). It is hypothesized that neuroactive immune factors (pro-inflammatory cytokines, brain-reactive antibodies) together with endocrine mediators (corticotropin-releasing factor, glucocorticoids) participate in the etiology of AABS. Since AABS develops natively, and has a considerable face and predictive validity, and since the principal pathway to autoimmunity is known, AABS may be a useful model for the study of CNS involvement in human autoimmune diseases and by extension, for testing autoimmune hypotheses of several mental disorders (major depression, schizophrenia, Alzheimer's disease, autism and AIDS-related dementia).

Entities:  

Mesh:

Year:  1997        PMID: 9168268     DOI: 10.1016/s0149-7634(96)00018-8

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  18 in total

1.  Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus.

Authors:  Minesh Kapadia; Hui Zhao; Donglai Ma; Boris Sakic
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-11       Impact factor: 4.147

Review 2.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

3.  Inhibition of C5a receptor alleviates experimental CNS lupus.

Authors:  Alexander Jacob; Bradley Hack; Tao Bai; James R Brorson; Richard J Quigg; Jessy J Alexander
Journal:  J Neuroimmunol       Date:  2010-03-05       Impact factor: 3.478

Review 4.  Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance.

Authors:  Mohtashem Samsam; Raheleh Ahangari; Saleh A Naser
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Behavioral heterogeneity in an animal model of neuropsychiatric lupus.

Authors:  Boris Sakic; Steven E Hanna; Jason M Millward
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

6.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

7.  Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of acute and chronic antidepressant treatments.

Authors:  Darrick T Balu
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

8.  Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?

Authors:  David A Ballok; Boris Sakic
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

9.  Effects of prolonged treatment with memantine in the MRL model of CNS lupus.

Authors:  Katarina Marcinko; Tiffany Parsons; Jason P Lerch; John G Sled; Boris Sakic
Journal:  Clin Exp Neuroimmunol       Date:  2012-09

10.  Depression is an early disease manifestation in lupus-prone MRL/lpr mice.

Authors:  Hua-Xin Gao; Sean R Campbell; Min-Hui Cui; Pu Zong; Jong Hee-Hwang; Maria Gulinello; Chaim Putterman
Journal:  J Neuroimmunol       Date:  2009-01-03       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.